文献速递免疫规划职业卫生卫生政策与健康促进

毛里塔尼亚医护人员乙肝与丁肝筛查及疫苗接种试点研究

From national HBV and HDV screenings to vaccination and treatment in healthcare workers: The Mauritanian pilot study.
PubMed 文献 · Vaccine · 2021-03-20

该前瞻性横断面试点研究在毛里塔尼亚医护人员中筛查HBV、HCV和HDV感染,并视结果提供治疗或疫苗接种。共纳入3857名医护人员,1363名抗-HBc阴性者完成全程疫苗接种,418名HBsAg阳性,48名抗-HDV阳性(其中10名HDV RNA阳性),HCV患病率为0.5%。结论认为毛里塔尼亚医护人员HBV免疫覆盖率低,HBV和HDV感染是严重健康问题,应依据WHO指南制定强制性筛查和免疫新建议。

要点

  • 毛里塔尼亚医护人员HBV免疫覆盖率低,仅1363/3857名抗-HBc阴性者接种疫苗。
  • 抗-HBc阳性者中418名HBsAg阳性,48名抗-HDV阳性,其中10名HDV RNA阳性。
  • 仅7名医护人员符合治疗标准,5名接受治疗;HCV患病率为0.5%。

核心结论

  • 毛里塔尼亚医护人员HBV免疫覆盖率低,HBV和HDV感染是严重健康问题。
  • 建议依据WHO指南制定强制性HBV筛查和免疫新建议。

研究设计与样本

  • 前瞻性横断面试点研究,纳入3857名医护人员。
  • 入组时筛查抗-HBc抗体,阳性者检测HBsAg,HBsAg阳性者进一步做生物学分析。
  • 根据结果提供HBV疫苗接种或抗病毒治疗。

主要发现

  • 1363名抗-HBc阴性医护人员接受全程疫苗接种。
  • 2494名抗-HBc阳性者中,1246名抗-HBs阳性,418名HBsAg阳性。
  • 3名HBeAg阳性;66名HBV DNA>2000 IU/mL,18名>20000 IU/mL。
  • 48名抗-HDV阳性,其中10名HDV RNA阳性;HCV患病率0.5%。
  • 仅7名符合治疗标准,5名接受治疗。

关键数值与推荐

  • 抗-HBc抗体阳性者进一步检测HBsAg。
  • HBsAg阳性者检测HBeAg、HBV DNA、抗-HDV抗体等。
  • 符合治疗标准者接受抗病毒治疗,抗-HBc阴性者接种HBV疫苗。

临床怎么用

  • 医护人员应常规筛查HBV标志物,阴性者接种疫苗。
  • HBsAg阳性者需评估HDV感染和病毒载量,符合标准者治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Hepatitis B and D infections are highly endemic in Mauritania, with prevalences ranging from 10 to 20%. With the present prospective transversal pilot study, we aimed to evaluate the prevalences of HBV, HCV, and HDV infections in healthcare workers (HCWs), and offer treatment or vaccination as required. METHODS: At inclusion, each HCW was screened for anti-HBc Ab (followed by HBsAg assay when positive). Additional biological analyses were performed for HBsAg + cases. Depending on the results, HBV vaccination or anti-viral treatment was offered. RESULTS: A total of 3,857 HCWs were included, of whom 1,363 tested negative for anti-HBc Ab and received full vaccination. Of the 2,494 HCWs who were positive for anti-HBc Ab, 1,246 were positive for anti-HBs Ab and 418 were positive for HBsAg. Three HCWs were positive for HBeAg; 66 and 18 had HBV DNA levels respectively > 2,000 and > 20,000 IU/mL; and 48 were positive for anti-HDV Ab among whom 10 were positive for HDV RNA. HCV prevalence was 0.5%. Only seven HCWs fulfilled the criteria for treatment and five of them were treated. CONCLUSION: Few HCWs in Mauritania are immunised against HBV. The prevalences of anti-HBc Ab and HBsAg observed in this work were similar to those observed in our earlier works, whereas prevalence of active HDV infection was less high. HBV and HDV infections are a serious health concern in Mauritania. New recommendations developed in accordance with WHO guidelines should include mandatory HBV screening and immunisation for HCWs.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. El Bara A, Pivert A, Veillon P, et al. From national HBV and HDV screenings to vaccination and treatment in healthcare workers: The Mauritanian pilot study. Vaccine. 2021. PMID: 33752951. doi:10.1016/j.vaccine.2021.03.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。